Neurent Medical, a company pioneering innovative treatments for chronic inflammatory sino-nasal diseases, based in Oranmore, County Galway, has added three executives to its leadership team.

Declan Daly has been appointed as chief financial officer. As chief financial officer of Inamed Corporation and Fibrocell Science, he managed a $3.2 billion M&A transaction and raised in excess of $250 million in financing.

Prasad Nalluri has been appointed vice-president of strategic marketing. Nalluri has more than two decades of experience in commercialicing ENT technologies, from pre-clinical stage through product launch and growth phases. He has held senior leadership roles in global marketing at large multinational organisations including Medtronic and Smith & Nephew, and at ENT start-ups ENTrigue Surgical and Aerin Medical.

Brent Shreiner has been appointed vice-president of sales. Shreiner has experience in sales leadership serving the ENT industry and has worked for several medical device start-ups. Shreiner previously held senior leadership roles with Arrinex (acquired by Stryker Corp), Spirox (acquired by Entellus Medical), Intersect ENT, and Access Closure (acquired by Cardinal Health).

Neurent Medical co-founder and chief executive Brian Shields said: “There are two vital components to a successful business: an innovative solution to an unmet need, and a motivated team that is focused on fulfilling that need. Our technology carries potential to improve the quality of life for patients suffering from chronic rhinitis, and we are making significant strides in cultivating a team that will bring our innovation into the hands of clinicians. Declan, Prasad, Brent and the entire team at Neurent Medical are real change-makers in the industry, and I couldn’t be more honoured to have some of the brightest industry experts supporting our mission.”